Sign up
Quantellect · Congress · Congressional Trade

Lisa C. McClain bought Colgate-Palmolive Company (NYSE: CL)

Lisa C. McClain bought Colgate-Palmolive Company (CL), disclosed August 13, 2025

Lisa C. McClain bought CL · disclosed August 13, 2025

Lisa C. McClain, a MI House member representing District 9, purchased $1,001 - $15,000 of Colgate-Palmolive Company (CL) on June 17, 2025. Filings associated with Lisa C. McClain disclosed 0 other CL transactions in the 12 months before this trade. Shares of CL have risen 2.3% since the first observed purchase on June 17, 2025. The filing was publicly disclosed on August 13, 2025; a direct filing link is not available in the current data record.

Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For Lisa C. McClain's complete filing history, visit Lisa C. McClain's full trade history. Browse all trading members of Congress tracked by Quantellect.

Key points

  • Analyst ratings on CL break down as 0 strong buy, 13 buy, 6 hold, 0 sell, 0 strong sell.
  • CL carries a Risk Score of 98 as of September 4, 2026. On this scale, a higher score means a lower risk surface.
  • Lisa C. McClain bought CL in the amount range of $1,001 - $15,000 on June 17, 2025, filed under the STOCK Act.
  • The filing lists Spouse as the transaction owner and was disclosed 57 days after the trade.
  • The asset description in the filing reads 'Colgate-Palmolive Company Common Stock (CL) [ST].'
  • Filings associated with Lisa C. McClain disclosed 0 other CL transactions in the 12 months before this trade.
  • Shares of CL have risen 2.3% since the first observed purchase on June 17, 2025.
  • CL carried a Q Score of 61 in its equity peer group as of September 8, 2026.
  • CL carried a Squeeze Score of 20 as of September 9, 2026.

Did Lisa C. McClain buy or sell CL?

The Periodic Transaction Report covers a single purchase involving CL on June 17, 2025. The filed amount range is $1,001 - $15,000. The asset description reads 'Colgate-Palmolive Company Common Stock (CL) [ST]', as submitted by the filer. The report was submitted on August 13, 2025. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.

PoliticianActionTickerAmountTrade dateFiled
Lisa C. McClain (House)BuyCL$1,001 - $15,000June 17, 2025August 13, 2025

What other CL trades has Lisa C. McClain disclosed in the past 12 months?

Filings associated with Lisa C. McClain disclosed 0 other CL transactions in the 12 months before this trade.

Trade dateActionOwnerAmountFiling
No other CL transactions were disclosed in the prior 12 months.

What does the filing show, and what does it not show?

The filing reports a purchase involving CL by Lisa C. McClain in the amount range of $1,001 - $15,000, with Spouse listed as the owner. It does not establish Lisa C. McClain's total holdings in CL, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'Colgate-Palmolive Company Common Stock (CL) [ST]', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify Lisa C. McClain's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with Lisa C. McClain disclosed 0 other CL transactions in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.

Who else in Congress traded CL?

Quantellect's current database lists these recent CL disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.

MemberPartyActionAmountDisclosed
Kevin Hern JointR HouseSell$1,001 - $15,000September 1, 2026Filing unavailable
Rohit Khanna SpouseD HouseSell$1,001 - $15,000September 4, 2026Filing unavailable
Rohit Khanna Dependent childD HouseBuy$1,001 - $15,000July 6, 2026Filing unavailable
Rohit Khanna SpouseD HouseBuy$1,001 - $15,000June 9, 2026Filing unavailable
Rohit Khanna SpouseD HouseBuy$1,001 - $15,000June 9, 2026Filing unavailable

How has Lisa C. McClain's disclosed trading performed?

Lisa C. McClain holds a Quantellect Q Score of 86 (strong), a descriptive rating of disclosed congressional buys over the trailing 24 months, based on estimated, unrealized results from filed amount ranges and closing prices.

Q Score rank #12 of 77 rated members. The rating covers buys only: entry uses the transaction-date close, positions are marked to the latest close, and dollar figures are estimates from the disclosed ranges, not realized gains. It describes disclosed activity and is not investment advice.

All Lisa C. McClain CL trades

TradedTypeSizeReturnEst. profit
September 11, 2025Sell$1,001 - $15,000+6.73%
September 11, 2025Sell$1,001 - $15,000+6.73%
August 13, 2025Buy$1,001 - $15,000+3.91%+$349
June 24, 2025Sell$1,001 - $15,000+2.35%
June 17, 2025Buy$1,001 - $15,000+1.83%+$182

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Frequently asked questions

Did Lisa C. McClain buy or sell CL?

According to the disclosure, Lisa C. McClain purchased CL on June 17, 2025.

What amount was reported for the CL transaction?

The disclosure reports $1,001 - $15,000 for the purchase. Filed amounts are ranges, not exact transaction values.

When did the transaction occur, and when was it disclosed?

The transaction is dated June 17, 2025, and it was disclosed on August 13, 2025.

Where can I see Lisa C. McClain's other congressional trades?

Quantellect lists Lisa C. McClain's complete disclosed trade history on the member profile. Lisa C. McClain's trade history

Is congressional stock trading legal?

The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act

Is Congress exempt from insider trading laws?

No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act

How quickly must members of Congress disclose a trade?

Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance

How is net worth reported in these disclosures?

It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act

Like this article? Share it
Methodology & disclaimer. Trades reflect Periodic Transaction Reports filed under the STOCK Act of 2012, which requires members of Congress to disclose covered transactions, generally within 30 days of receiving notice of the transaction and no later than 45 days after the transaction; disclosed amounts are the broad ranges in the official filing, not exact figures. Estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended. The Q Score measures a member's disclosed-trade track record against a sector-matched benchmark. This article is generated programmatically for education and research only. It is not investment advice, a recommendation, or an allegation of unlawful trading.

Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.